Anna Kucharska-Newton

Dr. Anna Kucharska-Newton


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Annals of Epidemiology
Verified
Journal Article
Closed access
AKAnna Kucharska-Newton
Anna Kucharska-Newton
WRWayne D. Rosamond
Wayne D. Rosamond
PMPamela J. Mink
Pamela J. Mink
AAAnthony J. Alberg
Anthony J. Alberg
ESEyal Shahar
Eyal Shahar
AFAaron R. Folsom
Aaron R. Folsom

1 August 2011 in Annals of Epidemiology
Verified
Journal Article
Closed access
AKAnna Kucharska-Newton
Anna Kucharska-Newton
KHKennet Harald
Kennet Harald
WRWayne D. Rosamond
Wayne D. Rosamond
KRKathryn M. Rose
Kathryn M. Rose
TRThomas D. Rea
Thomas D. Rea
VSVeikko Salomaa
Veikko Salomaa

1 January 2019 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
AKAnna Kucharska-Newton
Anna Kucharska-Newton
Lee StonerLee Stoner
Lee Stoner
MMMichelle L. Meyer
Michelle L. Meyer
BACKGROUND: Vascular age is an emerging health indicator and predictor of end-organ damage to the heart, brain, and kidney. Although there have been many review publications concerning risk factors for vascular aging, most include cross-sectional epidemiological studies, limiting inferences about temporality. There is a need for a review of longitudinal epidemiological studies with repeated measures of vascular structure and function to allow for a systematic examination of determinants of vascular age and the association of vascular aging with outcomes. CONTENT: Arterial stiffness is the most frequently used measure of vascular aging. We report here results of an extensive literature review of longitudinal cohort studies with repeated measures of arterial stiffness to characterize determinants of vascular age. Additionally, we summarize population-based studies that have focused on the association of arterial stiffness with end-organ damage and adverse cardiovascular outcomes. SUMMARY: Changes in arterial stiffness are evident in early childhood. In adults, arterial stiffness has been observed to progress at the average rate of 0.2 to 0.7 m/s for every 5 years of life. The state of the science is limited by the small number of studies with repeated measures of arterial stiffness and determinants of arterial stiffness progression, as well as limited studies in children and diverse race/ethnic groups. Several extant studies suggest that beyond age, cardiometabolic risk factors and adverse lifestyle behaviors contribute to arterial stiffening. Therefore, arterial stiffness is important in the assessment of healthy vascular aging and a possible target for the prevention of subclinical and clinical disease.

17 July 2017 in BMC Neurology
Verified
Journal Article
Open access
PDF file
PDPamela W. Duncan
Pamela W. Duncan
CBCheryl D. Bushnell
Cheryl D. Bushnell
WRWayne D. Rosamond
Wayne D. Rosamond
SBSara B. Jones Berkeley
Sara B. Jones Berkeley
SGSabina B. Gesell
Sabina B. Gesell
BVBetsy Vetter
Betsy Vetter
Patients discharged home after stroke face significant challenges managing residual neurological deficits, secondary prevention, and pre-existing chronic conditions. Post-discharge care is often fragmented leading to increased healthcare costs, readmissions, and sub-optimal utilization of rehabilitation and community services. The COMprehensive Post-Acute Stroke Services (COMPASS) Study is an ongoing cluster-randomized pragmatic trial to assess the effectiveness of a comprehensive, evidence-based, post-acute care model on patient-centered outcomes. Forty-one hospitals in North Carolina were randomized (as 40 units) to either implement the COMPASS care model or continue their usual care. The recruitment goal is 6000 patients (3000 per arm). Hospital staff ascertain and enroll patients discharged home with a clinical diagnosis of stroke or transient ischemic attack. Patients discharged from intervention hospitals receive 2-day telephone follow-up; a comprehensive clinic visit within 2 weeks that includes a neurological evaluation, assessments of social and functional determinants of health, and an individualized COMPASS Care Plan™ integrated with a community-specific resource database; and additional follow-up calls at 30 and 60 days post-stroke discharge. This model is consistent with the Centers for Medicare and Medicaid Services transitional care management services provided by physicians or advanced practice providers with support from a nurse to conduct patient assessments and coordinate follow-up services. Patients discharged from usual care hospitals represent the control group and receive the standard of care in place at that hospital. Patient-centered outcomes are collected from telephone surveys administered at 90 days. The primary endpoint is patient-reported functional status as measured by the Stroke Impact Scale 16. Secondary outcomes are: caregiver strain, all-cause readmissions, mortality, healthcare utilization, and medication adherence. The study engages patients, caregivers, and other stakeholders (including policymakers, advocacy groups, payers, and local community coalitions) to advise and support the design, implementation, and sustainability of the COMPASS care model. Given the high societal and economic burden of stroke, identifying a care model to improve recovery, independence, and quality of life is critical for stroke survivors and their caregivers. The pragmatic trial design provides a real-world assessment of the COMPASS care model effectiveness and will facilitate rapid implementation into clinical practice if successful. Clinicaltrials.gov: NCT02588664 ; October 23, 2015.

1 January 2016 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
AKAnna Kucharska-Newton
Anna Kucharska-Newton
GHGerardo Heiss
Gerardo Heiss
HNHanyu Ni
Hanyu Ni
SSSally C. Stearns
Sally C. Stearns
NPNicole Puccinelli-Ortega
Nicole Puccinelli-Ortega
LCLloyd Chambless
Lloyd Chambless

24 October 2009 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
AKAnna Kucharska-Newton
Anna Kucharska-Newton
DCDavid J. Couper
David J. Couper
JPJames S. Pankow
James S. Pankow
RPRonald J. Prineas
Ronald J. Prineas
TRThomas D. Rea
Thomas D. Rea
WRWayne D. Rosamond
Wayne D. Rosamond